Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126812301 | 12681230 | 1 | I | 20160810 | 20160824 | 20160824 | EXP | US-SA-2016SA153582 | AVENTIS | 60.00 | YR | A | M | Y | 0.00000 | 20160824 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126812301 | 12681230 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | U | UNK | 20839 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126812301 | 12681230 | 1 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126812301 | 12681230 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126812301 | 12681230 | Blood bilirubin increased | |
| 126812301 | 12681230 | Jaundice cholestatic | |
| 126812301 | 12681230 | Leukopenia | |
| 126812301 | 12681230 | Liver function test abnormal | |
| 126812301 | 12681230 | Lymphopenia | |
| 126812301 | 12681230 | Mouth ulceration | |
| 126812301 | 12681230 | Pyrexia | |
| 126812301 | 12681230 | Thrombocytopenia | |
| 126812301 | 12681230 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126812301 | 12681230 | 1 | 201607 | 20160808 | 0 |